Unbound MEDLINE

Articles related to 10740332 journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:Bookmark this site
Articles related to 10740332 [Unique ID], provided by the PubMed system
1 - 10 of 181 journal articles in the PubMed databaseEmail to a friend    
 
Alexandersen P, Byrjalsen I, Christiansen C 
Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects. [Clinical Trial, Journal Article, Randomized Controlled Trial]
BJOG 2000 Mar; 107(3):356-64.
Abstract | Full Citation | Find Related Articles 
Byrjalsen I, Alexandersen P, Christiansen C 
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium. [Clinical Trial, Journal Article, Randomized Controlled Trial]
BJOG 2000 Mar; 107(3):347-55.
Abstract | Full Citation | Find Related Articles 
Saure A, Hirvonen E, Milsom I, et al. 
A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Maturitas 1996 May; 24(1-2):111-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Christiansen C, Riis BJ 
Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Br J Obstet Gynaecol 1990 Dec; 97(12):1087-92.
Abstract | Full Citation | Find Related Articles 
Alexandersen P, Riis BJ, Christiansen C 
Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Clin Endocrinol Metab 1999 Sep; 84(9):3013-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Marslew U, Riis BJ, Christiansen C 
Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. [Clinical Trial, Comparative Study , Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't ]
Eur J Clin Invest 1991 Dec; 21(6):601-7.
Abstract | Full Citation | Find Related Articles 
Perry W, Wiseman RA 
Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites. [Clinical Trial, Journal Article]
BJOG 2000 Nov; 107(11):1401-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Delmas PD, Confavreux E, Garnero P, et al. 
A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Osteoporos Int 2000; 11(2):177-87.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Greenwald MW, Gluck OS, Lang E, et al. 
Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects. [Journal Article]
Menopause 2005 Nov-Dec; 12(6):741-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
New Search Next Results
  
Merck Manual for Mobile + Web!

Advertise on this site.